Teva Agrees to Pay New York $523 Million

Teva Pharmaceuticals has agreed to settle yet another case relating to its role in the US opioid crisis, this time with the state of New York. According to the state’s Attorney General Tish James, the pharma giant will pay an additional $313 million on top of the $210 million the state will receive from a nationwide settlement Teva reached this summer.

According to Shannon Young, “Under the agreement, funds will be paid out over an 18-year period. It commits Teva to injunctive relief that includes a ban on high-dose opioids and prescription savings programs, restrictions on political lobbying and disclosure of opioid product clinical data, among other things. James’ office noted that it has also secured injunctive relief from Teva’s distributor, Anda, Inc.”

To read more, click here.

(Source: Politico, November 3^rd, 2022)